ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BHZPJ890
Stock Name / FundiShares MSCI USA ESG Enhanced UCITS ETF USD (Dist)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity Type
Entity LEI 549300ZP07LMR36K1T02
ETF TickerEEDG(GBP) LSE
ETF TickerEEDS(USD) LSE
ETF TickerEEDG.LS(GBP) CXE
ETF TickerEEDS.LS(USD) CXE
ETF TickerOM3L.DE(EUR) CXE
ETF TickerEEDG.L(GBP) LSE
ETF TickerEEDS.L(GBP) LSE

Holdings detail for RPRX

Stock NameRoyalty Pharma Plc
TickerRPRX(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINGB00BMVP7Y09
LEI549300FGFN7VOK8BZR03

Show aggregate RPRX holdings

News associated with RPRX

Royalty Pharma Expects At Least Mid-teens Average Annual Total Shareholder Return Over 2025-2030.
(RTTNews) - Royalty Pharma plc (RPRX) Thursday said it will host an Investor Day today, where senior executives will provide updates on the company's strategies aimed at driving shareholder value creation. - 2025-09-11 08:35:29
Maryland State Retirement & Pension System Trims Stock Position in Royalty Pharma PLC (NASDAQ:RPRX)
Maryland State Retirement & Pension System lessened its position in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 18.4% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 18,291 shares of the biopharmaceutical company’s stock after selling 4,133 shares during the quarter. […] - 2025-08-15 05:22:58
PNC Financial Services Group Inc. Acquires 859 Shares of Royalty Pharma PLC (NASDAQ:RPRX)
PNC Financial Services Group Inc. boosted its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 7.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 12,665 shares of the biopharmaceutical company’s stock after purchasing an additional […] - 2025-08-15 04:48:59
Blair William & Co. IL Invests $212,000 in Royalty Pharma PLC (NASDAQ:RPRX)
Blair William & Co. IL bought a new position in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 6,801 shares of the biopharmaceutical company’s stock, valued at approximately $212,000. A number of other hedge […] - 2025-08-13 07:56:48
Deutsche Bank AG Sells 1,775,038 Shares of Royalty Pharma PLC (NASDAQ:RPRX)
Deutsche Bank AG lessened its holdings in Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 55.6% during the 1st quarter, Holdings Channel.com reports. The firm owned 1,414,926 shares of the biopharmaceutical company’s stock after selling 1,775,038 shares during the period. Deutsche Bank AG’s holdings in Royalty Pharma were worth $44,047,000 as of its most recent […] - 2025-08-13 05:54:50
Charles Schwab Investment Management Inc. Has $97.20 Million Stock Holdings in Royalty Pharma PLC (NASDAQ:RPRX)
Charles Schwab Investment Management Inc. cut its holdings in Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 0.3% in the 1st quarter, Holdings Channel.com reports. The firm owned 3,122,531 shares of the biopharmaceutical company’s stock after selling 9,097 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Royalty Pharma were worth $97,204,000 as […] - 2025-08-13 05:10:46
Royalty Pharma (NASDAQ:RPRX) Raised to Buy at Wall Street Zen
Royalty Pharma (NASDAQ:RPRX – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “hold” rating to a “buy” rating in a report released on Saturday. A number of other equities research analysts also recently weighed in on the company. Morgan Stanley boosted their target price on Royalty Pharma from $51.00 […] - 2025-08-11 03:50:55
Allianz Asset Management GmbH Has $6.03 Million Stock Holdings in Royalty Pharma PLC (NASDAQ:RPRX)
Allianz Asset Management GmbH reduced its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 64.8% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 193,591 shares of the biopharmaceutical company’s stock after selling 356,968 shares during the period. Allianz […] - 2025-07-28 07:00:47
Edgestream Partners L.P. Invests $659,000 in Royalty Pharma PLC (NASDAQ:RPRX)
Edgestream Partners L.P. acquired a new position in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 21,158 shares of the biopharmaceutical company’s stock, valued at approximately $659,000. Other hedge funds and other institutional investors also […] - 2025-07-20 05:24:59
Cerity Partners LLC Boosts Stake in Royalty Pharma PLC (NASDAQ:RPRX)
Cerity Partners LLC raised its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 786.3% during the 1st quarter, Holdings Channel reports. The fund owned 153,846 shares of the biopharmaceutical company’s stock after purchasing an additional 136,487 shares during the period. Cerity Partners LLC’s holdings in Royalty Pharma were worth $4,789,000 as […] - 2025-07-17 05:00:57
Xponance Inc. Acquires 1,437 Shares of Royalty Pharma PLC (NASDAQ:RPRX)
Xponance Inc. raised its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 3.7% in the first quarter, HoldingsChannel.com reports. The firm owned 40,133 shares of the biopharmaceutical company’s stock after buying an additional 1,437 shares during the period. Xponance Inc.’s holdings in Royalty Pharma were worth $1,249,000 as of its most […] - 2025-07-16 05:48:56
M&T Bank Corp Buys 5,500 Shares of Royalty Pharma PLC (NASDAQ:RPRX)
M&T Bank Corp raised its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 23.4% in the 1st quarter, Holdings Channel reports. The firm owned 28,967 shares of the biopharmaceutical company’s stock after acquiring an additional 5,500 shares during the period. M&T Bank Corp’s holdings in Royalty Pharma were worth $902,000 at […] - 2025-07-15 06:23:30
Teacher Retirement System of Texas Cuts Stock Position in Royalty Pharma PLC (NASDAQ:RPRX)
Teacher Retirement System of Texas cut its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 10.4% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 103,364 shares of the biopharmaceutical company’s stock after selling 12,028 shares during the […] - 2025-07-09 05:33:01
Allspring Global Investments Holdings LLC Boosts Stake in Royalty Pharma PLC (NASDAQ:RPRX)
Allspring Global Investments Holdings LLC boosted its position in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 4.0% in the first quarter, Holdings Channel.com reports. The institutional investor owned 561,724 shares of the biopharmaceutical company’s stock after acquiring an additional 21,729 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Royalty […] - 2025-07-03 06:09:03
11,210 Shares in Royalty Pharma PLC (NASDAQ:RPRX) Acquired by Kentucky Retirement Systems Insurance Trust Fund
Kentucky Retirement Systems Insurance Trust Fund acquired a new stake in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) in the first quarter, HoldingsChannel reports. The firm acquired 11,210 shares of the biopharmaceutical company’s stock, valued at approximately $349,000. Other hedge funds also recently bought and sold shares of the company. Louisbourg Investments Inc. […] - 2025-06-26 05:42:57
After Hours Most Active for Jun 24, 2025 : SNAP, NVDA, CMCSA, PLTR, INTC, SPR, AUR, RPRX, KVUE, MPW, GM, WMT
The NASDAQ 100 After Hours Indicator is down -.81 to 22,189.71. The total After hours volume is currently 173,627,396 shares traded.The following are the most active stocks for the after hours session: Snap Inc. (SNAP) is unchanged at $8.32, with 14,501,942 shares traded. SNAP's - 2025-06-24 17:24:56
Manning & Napier Advisors LLC Sells 44,505 Shares of Royalty Pharma PLC (NASDAQ:RPRX)
Manning & Napier Advisors LLC lessened its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 54.9% during the first quarter, HoldingsChannel.com reports. The firm owned 36,549 shares of the biopharmaceutical company’s stock after selling 44,505 shares during the quarter. Manning & Napier Advisors LLC’s holdings in Royalty Pharma were worth $1,138,000 […] - 2025-06-24 05:20:57
After Hours Most Active for Jun 11, 2025 : PLTR, NVDA, AMZN, AAPL, RPRX, MCHPP
The NASDAQ 100 After Hours Indicator is up 14.32 to 21,875.12. The total After hours volume is currently 131,070,110 shares traded.The following are the most active stocks for the after hours session: Palantir Technologies Inc. (PLTR) is +0.25 at $136.64, with 5,538,416 shares t - 2025-06-11 17:24:56
Rhumbline Advisers Has $14.01 Million Position in Royalty Pharma plc (NASDAQ:RPRX)
Rhumbline Advisers lowered its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 0.9% during the first quarter, HoldingsChannel reports. The firm owned 449,964 shares of the biopharmaceutical company’s stock after selling 4,184 shares during the quarter. Rhumbline Advisers’ holdings in Royalty Pharma were worth $14,007,000 as of its most recent SEC […] - 2025-06-09 05:24:51
Lazard Asset Management LLC Reduces Holdings in Royalty Pharma plc (NASDAQ:RPRX)
Lazard Asset Management LLC lowered its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 4.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 23,457 shares of the biopharmaceutical company’s stock after selling 1,130 shares during the quarter. Lazard Asset […] - 2025-05-22 05:46:49
Royalty Pharma plc (NASDAQ:RPRX) Receives Average Rating of “Buy” from Brokerages
Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) has received a consensus recommendation of “Buy” from the five research firms that are covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. […] - 2025-05-22 04:50:51
Captrust Financial Advisors Sells 14,499 Shares of Royalty Pharma plc (NASDAQ:RPRX)
Captrust Financial Advisors reduced its position in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 49.4% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 14,829 shares of the biopharmaceutical company’s stock after selling 14,499 shares during the quarter. Captrust Financial Advisors’ holdings in Royalty Pharma were worth $378,000 as of […] - 2025-05-20 04:52:44
Analysts Predict 10% Gains Ahead For The Holdings of EUSA
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-19 07:59:43
Royalty Pharma (NASDAQ:RPRX) Raised to “Buy” at StockNews.com
Royalty Pharma (NASDAQ:RPRX – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Monday. Separately, Citigroup reiterated a “buy” rating on shares of Royalty Pharma in a research report on Friday, March 28th. One equities research analyst has rated […] - 2025-05-14 02:14:45
Stifel Financial Corp Lowers Stake in Royalty Pharma plc (NASDAQ:RPRX)
Stifel Financial Corp reduced its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 11.4% in the fourth quarter, Holdings Channel reports. The firm owned 17,152 shares of the biopharmaceutical company’s stock after selling 2,200 shares during the period. Stifel Financial Corp’s holdings in Royalty Pharma were worth $438,000 at the end […] - 2025-05-13 04:50:58
Prudential Financial Inc. Has $488,000 Stake in Royalty Pharma plc (NASDAQ:RPRX)
Prudential Financial Inc. lowered its holdings in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 4.9% during the fourth quarter, Holdings Channel.com reports. The firm owned 18,360 shares of the biopharmaceutical company’s stock after selling 955 shares during the period. Prudential Financial Inc.’s holdings in Royalty Pharma were worth $488,000 at the end of the […] - 2025-04-10 05:01:02
American Century Companies Inc. Boosts Holdings in Royalty Pharma plc (NASDAQ:RPRX)
American Century Companies Inc. grew its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 5.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 67,160 shares of the biopharmaceutical company’s stock after buying an additional 3,671 shares […] - 2025-04-10 04:26:56
Royalty Pharma plc (NASDAQ:RPRX) Shares Purchased by JPMorgan Chase & Co.
JPMorgan Chase & Co. lifted its stake in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 8.2% in the 4th quarter, Holdings Channel reports. The firm owned 1,395,242 shares of the biopharmaceutical company’s stock after purchasing an additional 105,824 shares during the quarter. JPMorgan Chase & Co.’s holdings in Royalty Pharma were worth $35,593,000 at […] - 2025-04-08 04:44:55
Schroder Investment Management Group Sells 354,483 Shares of Royalty Pharma plc (NASDAQ:RPRX)
Schroder Investment Management Group lowered its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 64.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 196,359 shares of the biopharmaceutical company’s stock after selling 354,483 shares during the quarter. Schroder Investment Management […] - 2025-04-06 05:29:08
Analysts Set Royalty Pharma plc (NASDAQ:RPRX) PT at $41.60
Shares of Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) have earned a consensus rating of “Buy” from the six research firms that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating […] - 2025-03-31 02:14:52

iShares MSCI USA ESG Enhanced UCITS ETF USD (Dist) RPRX holdings

DateNumber of RPRX Shares HeldBase Market Value of RPRX SharesLocal Market Value of RPRX SharesChange in RPRX Shares HeldChange in RPRX Base ValueCurrent Price per RPRX Share HeldPrevious Price per RPRX Share Held
2025-12-18 (Thursday)59,323USD 2,279,783USD 2,279,783
2025-12-17 (Wednesday)59,315RPRX holding decreased by -168USD 2,272,358RPRX holding decreased by -10600USD 2,272,358-168USD -10,600 USD 38.31 USD 38.38
2025-12-16 (Tuesday)59,483RPRX holding increased by 8USD 2,282,958RPRX holding decreased by -8614USD 2,282,9588USD -8,614 USD 38.38 USD 38.53
2025-12-15 (Monday)59,475RPRX holding increased by 35USD 2,291,572RPRX holding increased by 9670USD 2,291,57235USD 9,670 USD 38.53 USD 38.39
2025-12-12 (Friday)59,440RPRX holding decreased by -8USD 2,281,902RPRX holding decreased by -25275USD 2,281,902-8USD -25,275 USD 38.39 USD 38.81
2025-12-11 (Thursday)59,448RPRX holding increased by 40USD 2,307,177RPRX holding increased by 34227USD 2,307,17740USD 34,227 USD 38.81 USD 38.26
2025-12-10 (Wednesday)59,408USD 2,272,950RPRX holding increased by 10099USD 2,272,9500USD 10,099 USD 38.26 USD 38.09
2025-12-09 (Tuesday)59,408RPRX holding decreased by -48USD 2,262,851RPRX holding decreased by -36313USD 2,262,851-48USD -36,313 USD 38.09 USD 38.67
2025-12-08 (Monday)59,456USD 2,299,164RPRX holding decreased by -63023USD 2,299,1640USD -63,023 USD 38.67 USD 39.73
2025-12-05 (Friday)59,456USD 2,362,187RPRX holding increased by 34485USD 2,362,1870USD 34,485 USD 39.73 USD 39.15
2025-12-04 (Thursday)59,456USD 2,327,702RPRX holding decreased by -26756USD 2,327,7020USD -26,756 USD 39.15 USD 39.6
2025-12-03 (Wednesday)59,456USD 2,354,458RPRX holding increased by 4162USD 2,354,4580USD 4,162 USD 39.6 USD 39.53
2025-12-02 (Tuesday)59,456USD 2,350,296RPRX holding decreased by -21998USD 2,350,2960USD -21,998 USD 39.53 USD 39.9
2025-12-01 (Monday)59,456USD 2,372,294RPRX holding decreased by -7135USD 2,372,2940USD -7,135 USD 39.9 USD 40.02
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of RPRX by Blackrock for IE00BHZPJ890

Show aggregate share trades of RPRX

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-12-17SELL-16838.89538.300 38.359USD -6,444 33.03 Loss of -896 on sale
2025-12-16BUY838.66537.830 37.914USD 303 33.01
2025-12-15BUY3538.58038.028 38.083USD 1,333 32.98
2025-12-12SELL-8 38.390* 32.96 Profit of 264 on sale
2025-12-11BUY4038.81037.935 38.023USD 1,521 32.93
2025-12-09SELL-4839.11038.070 38.174USD -1,832 32.88 Loss of -254 on sale
2025-11-28SELL-9 40.020* 32.67 Profit of 294 on sale
2025-11-26BUY9639.87039.235 39.299USD 3,773 32.61
2025-11-24SELL-852,32639.83037.310 37.562USD -32,015,070 32.54 Loss of -4,280,542 on sale
2025-11-21SELL-642 38.920* 32.51 Profit of 20,871 on sale
2025-11-19SELL-6,549 38.650* 32.45 Profit of 212,534 on sale
2025-11-18SELL-5,328 39.460* 32.42 Profit of 172,731 on sale
2025-11-17BUY22039.49538.965 39.018USD 8,584 32.39
2025-11-14BUY42439.64538.820 38.902USD 16,495 32.35
2025-11-13BUY4,34640.01039.380 39.443USD 171,419 32.32
2025-11-12SELL-2,258 39.590* 32.28 Profit of 72,897 on sale
2025-11-10SELL-1,98039.39938.510 38.599USD -76,426 32.22 Loss of -12,629 on sale
2025-11-06BUY9141.24040.020 40.142USD 3,653 32.15
2025-11-05BUY88040.81536.027 36.506USD 32,125 32.11
2025-11-03BUY1,26837.71537.130 37.189USD 47,155 32.08
2025-10-31BUY42437.61036.670 36.764USD 15,588 32.05
2025-10-30BUY3,26537.21036.454 36.530USD 119,270 32.03
2025-10-29BUY86636.67036.980 36.949USD 31,998 32.00
2025-10-24BUY14,64037.26037.395 37.382USD 547,265 31.98
2025-10-22BUY21,83636.84037.690 37.605USD 821,143 31.95
2025-10-20BUY53236.63036.920 36.891USD 19,626 31.90
2025-10-17BUY4,66937.01037.130 37.118USD 173,304 31.87
2025-10-14SELL-66636.00036.130 36.117USD -24,054 31.80 Loss of -2,872 on sale
2025-10-13BUY11035.44035.975 35.921USD 3,951 31.78
2025-10-06BUY2,01436.13036.220 36.211USD 72,929 31.76
2025-10-03BUY42436.07036.670 36.610USD 15,523 31.74
2025-10-02BUY44036.49036.600 36.589USD 16,099 31.71
2025-10-01BUY3,83636.32036.455 36.442USD 139,790 31.69
2025-09-29BUY21235.25035.290 35.286USD 7,481 31.65
2025-09-26SELL-10,86835.04035.220 35.202USD -382,575 31.63 Loss of -38,823 on sale
2025-09-25BUY5,81034.90035.996 35.886USD 208,500 31.61
2025-09-18BUY2,96835.73035.810 35.802USD 106,260 31.59
2025-09-17BUY4,73035.64035.840 35.820USD 169,429 31.57
2025-09-11SELL-5,96836.70036.940 36.916USD -220,315 31.51 Loss of -32,235 on sale
2025-09-10BUY1,08836.18036.760 36.702USD 39,932 31.49
2025-09-09BUY1,43036.50036.570 36.563USD 52,285 31.46
2025-08-27BUY84036.06036.190 36.177USD 30,389 31.41
2025-08-21BUY21036.31036.900 36.841USD 7,737 31.35
2025-08-19BUY64536.00036.220 36.198USD 23,348 31.29
2025-07-21BUY10935.65035.920 35.893USD 3,912 31.26
2025-07-18BUY4,97535.59035.650 35.644USD 177,329 31.24
2025-07-17BUY65435.47035.790 35.758USD 23,386 31.21
2025-07-16BUY9,55335.60036.890 36.761USD 351,178 31.19
2025-07-15BUY5,99536.51036.690 36.672USD 219,849 31.15
2025-07-03SELL-84036.37036.430 36.424USD -30,596 31.09 Loss of -4,482 on sale
2025-07-02SELL-6,82236.19036.245 36.239USD -247,226 31.06 Loss of -35,361 on sale
2025-06-30SELL-13936.03036.220 36.201USD -5,032 31.02 Loss of -719 on sale
2025-06-27BUY43635.87035.931 35.925USD 15,663 30.99
2025-06-26BUY21835.27036.140 36.053USD 7,860 30.97
2025-06-25BUY43635.91036.040 36.027USD 15,708 30.94
2025-06-24SELL-32736.14036.320 36.302USD -11,871 30.90 Loss of -1,766 on sale
2025-06-17SELL-44034.56035.140 35.082USD -15,436 30.77 Loss of -1,898 on sale
2025-06-13SELL-19834.84035.380 35.326USD -6,995 30.71 Loss of -914 on sale
2025-06-12BUY31535.27035.370 35.360USD 11,138 30.68
2025-06-06SELL-1,52633.78033.970 33.951USD -51,809 30.60 Loss of -5,121 on sale
2025-06-05SELL-2,39833.75033.770 33.768USD -80,976 30.57 Loss of -7,662 on sale
2025-06-04SELL-3,07433.44033.715 33.688USD -103,555 30.55 Loss of -9,637 on sale
2025-06-03BUY63633.29033.540 33.515USD 21,316 30.53
2025-06-02SELL-18633.26033.270 33.269USD -6,188 30.51 Loss of -513 on sale
2025-05-30BUY1,16632.88033.110 33.087USD 38,579 30.50
2025-05-29SELL-66332.64032.770 32.757USD -21,718 30.48 Loss of -1,509 on sale
2025-05-28SELL-43632.63032.820 32.801USD -14,301 30.46 Loss of -1,019 on sale
2025-05-23SELL-1,93232.45032.600 32.585USD -62,954 30.42 Loss of -4,186 on sale
2025-05-22BUY10632.31032.930 32.868USD 3,484 30.40
2025-05-21SELL-54532.83033.325 33.276USD -18,135 30.39 Loss of -1,575 on sale
2025-05-20BUY2,33233.09033.800 33.729USD 78,656 30.36
2025-05-16SELL-98134.02034.200 34.182USD -33,533 30.31 Loss of -3,803 on sale
2025-05-15BUY11533.12033.130 33.129USD 3,810 30.28
2025-05-14BUY1,92032.29033.110 33.028USD 63,414 30.27
2025-05-13BUY6,93432.82033.090 33.063USD 229,259 30.25
2025-05-12BUY5,56533.35033.600 33.575USD 186,845 30.22
2025-05-09BUY1,78533.15033.720 33.663USD 60,088 30.20
2025-05-08SELL-1,74433.10034.110 34.009USD -59,312 30.17 Loss of -6,687 on sale
2025-05-07BUY4,93532.75032.825 32.818USD 161,954 30.15
2025-05-06BUY1,15532.11033.040 32.947USD 38,054 30.14
2025-05-02SELL-19032.89032.970 32.962USD -6,263 30.09 Loss of -546 on sale
2025-05-01SELL-10532.48032.690 32.669USD -3,430 30.07 Loss of -273 on sale
2025-04-29BUY432.71032.910 32.890USD 132 30.02
2025-04-28SELL-14,57332.54032.670 32.657USD -475,910 30.00 Loss of -38,720 on sale
2025-04-25SELL-21032.20032.300 32.290USD -6,781 29.98 Loss of -485 on sale
2025-04-24SELL-3,25532.03032.130 32.120USD -104,551 29.96 Loss of -7,024 on sale
2025-04-23SELL-1,15531.69032.480 32.401USD -37,423 29.95 Loss of -2,835 on sale
2025-04-22SELL-75632.19032.730 32.676USD -24,703 29.93 Loss of -2,079 on sale
2025-04-16SELL-4,09532.19032.610 32.568USD -133,366 29.83 Loss of -11,199 on sale
2025-04-11BUY2,07731.95032.005 32.000USD 66,463 29.76
2025-04-10BUY65431.21031.970 31.894USD 20,859 29.75
2025-04-09BUY1,07532.27032.310 32.306USD 34,729 29.72
2025-04-08SELL-2,99730.85031.600 31.525USD -94,480 29.71 Loss of -5,431 on sale
2025-04-07BUY2,05131.03031.140 31.129USD 63,846 29.70
2025-04-04BUY4,45131.11031.700 31.641USD 140,834 29.69
2025-04-02BUY1,81731.28031.360 31.352USD 56,967 29.67
2025-04-01BUY87231.17031.505 31.471USD 27,443 29.65
2025-03-31SELL-4,64431.13031.310 31.292USD -145,320 29.64 Loss of -7,683 on sale
2025-03-28SELL-44031.37031.795 31.753USD -13,971 29.62 Loss of -939 on sale
2025-03-26BUY11031.56034.000 33.756USD 3,713 29.58
2025-03-25BUY33033.76034.140 34.102USD 11,254 29.53
2025-03-24BUY66033.75033.990 33.966USD 22,418 29.48
2025-03-21BUY16,94033.70033.840 33.826USD 573,012 29.44
2025-03-20BUY22033.50033.510 33.509USD 7,372 29.39
2025-03-19SELL-3,07433.41033.500 33.491USD -102,951 29.34 Loss of -12,750 on sale
2025-03-17SELL-22033.02033.265 33.240USD -7,313 29.25 Loss of -877 on sale
2025-03-14SELL-44032.77032.955 32.937USD -14,492 29.21 Loss of -1,640 on sale
2025-03-13SELL-10632.68033.130 33.085USD -3,507 29.17 Loss of -415 on sale
2025-03-12SELL-70032.85032.915 32.909USD -23,036 29.12 Loss of -2,649 on sale
2025-03-11BUY11032.46032.770 32.739USD 3,601 29.08
2025-03-06BUY6,51033.28033.790 33.739USD 219,641 28.93
2025-03-05SELL-53733.77033.790 33.788USD -18,144 28.87 Loss of -2,642 on sale
2025-03-03BUY32733.86034.100 34.076USD 11,143 28.74
2025-02-28BUY2,18933.64033.730 33.721USD 73,815 28.68
2025-02-27SELL-2,14033.37033.620 33.595USD -71,893 28.61 Loss of -10,664 on sale
2025-02-26SELL-27,49933.38033.870 33.821USD -930,044 28.55 Loss of -145,062 on sale
2025-02-25SELL-1,88733.69034.115 34.073USD -64,295 28.47 Loss of -10,566 on sale
2025-02-24BUY2,67533.80034.200 34.160USD 91,378 28.40
2025-02-21BUY1,39933.42033.670 33.645USD 47,069 28.32
2025-02-20BUY25833.33033.690 33.654USD 8,683 28.25
2025-02-19BUY22232.59032.915 32.883USD 7,300 28.19
2025-02-18SELL-1,20132.85032.870 32.868USD -39,474 28.12 Loss of -5,708 on sale
2025-02-14BUY33332.36032.890 32.837USD 10,935 27.98
2025-02-13SELL-22232.46032.630 32.613USD -7,240 27.91 Loss of -1,044 on sale
2025-02-12SELL-4,21832.34032.560 32.538USD -137,245 27.84 Loss of -19,815 on sale
2025-02-10SELL-4431.72031.790 31.783USD -1,398 27.70 Loss of -180 on sale
2025-02-06BUY60731.40031.625 31.602USD 19,183 27.57
2025-02-05SELL-1,66531.45031.635 31.617USD -52,641 27.50 Loss of -6,853 on sale
2025-02-03BUY19631.33031.660 31.627USD 6,199 27.36
2025-01-30SELL-2,24731.59032.060 32.013USD -71,933 27.20 Loss of -10,807 on sale
2025-01-29SELL-1631.95032.210 32.184USD -515 27.11 Loss of -81 on sale
2025-01-28SELL-1,47931.94032.120 32.102USD -47,479 27.02 Loss of -7,520 on sale
2025-01-27BUY66631.72031.760 31.756USD 21,149 26.92
2025-01-24BUY1,17731.06031.100 31.096USD 36,600 26.84
2025-01-23BUY1,17730.62030.645 30.643USD 36,066 26.76
2024-12-09BUY22026.01026.220 26.199USD 5,764 26.80
2024-12-06BUY3,41025.91026.590 26.522USD 90,440 26.82
2024-12-04BUY2,53026.10026.355 26.329USD 66,614 26.85
2024-12-03BUY1,46626.34026.470 26.457USD 38,786 26.86
2024-12-02BUY3,30026.43026.600 26.583USD 87,724 26.87
2024-11-29BUY33026.66026.660 26.660USD 8,798 26.88
2024-11-27BUY10926.60026.645 26.641USD 2,904 26.89
2024-11-26SELL-3,73626.29026.620 26.587USD -99,329 26.91 Profit of 1,198 on sale
2024-11-25BUY637,71226.47026.830 26.794USD 17,086,855 26.92
2024-11-22SELL-3226.43026.630 26.610USD -852 26.93 Profit of 10 on sale
2024-11-21BUY76226.40026.665 26.639USD 20,299 26.95
2024-11-19SELL-16326.01026.030 26.028USD -4,243 27.00 Profit of 159 on sale
2024-11-18BUY34025.80025.940 25.926USD 8,815 27.04
2024-11-12BUY1726.00026.410 26.369USD 448 27.08
2024-11-08BUY4726.21026.800 26.741USD 1,257 27.17
2024-11-08BUY4726.21026.800 26.741USD 1,257 27.17
2024-11-07BUY1,23226.52027.030 26.979USD 33,238 27.22
2024-11-07BUY1,23226.52027.030 26.979USD 33,238 27.22
2024-11-06BUY3426.64028.360 28.188USD 958 27.27
2024-11-06BUY3426.64028.360 28.188USD 958 27.27
2024-11-05SELL-9027.54027.565 27.563USD -2,481 27.24 Loss of -29 on sale
2024-11-05SELL-9027.54027.565 27.563USD -2,481 27.24 Loss of -29 on sale
2024-11-04SELL-57627.20027.593 27.554USD -15,871 27.25 Loss of -177 on sale
2024-11-04SELL-57627.20027.593 27.554USD -15,871 27.25 Loss of -177 on sale
2024-11-01SELL-17027.10027.270 27.253USD -4,633 27.26 Profit of 2 on sale
2024-11-01SELL-17027.10027.270 27.253USD -4,633 27.26 Profit of 2 on sale
2024-10-31BUY10227.00027.260 27.234USD 2,778 27.30
2024-10-31BUY10227.00027.260 27.234USD 2,778 27.30
2024-10-30SELL-68427.19027.370 27.352USD -18,709 27.31 Loss of -26 on sale
2024-10-30SELL-68427.19027.370 27.352USD -18,709 27.31 Loss of -26 on sale
2024-10-29SELL-64827.15027.330 27.312USD -17,698 27.33 Profit of 11 on sale
2024-10-28BUY5427.26027.275 27.273USD 1,473 27.34
2024-10-28BUY5427.26027.275 27.273USD 1,473 27.34
2024-10-25BUY1,15226.95027.380 27.337USD 31,492 27.44
2024-10-25BUY1,15226.95027.380 27.337USD 31,492 27.44
2024-10-24BUY15227.28027.450 27.433USD 4,170 27.49
2024-10-24BUY15227.28027.450 27.433USD 4,170 27.49
2024-10-23SELL-2427.36027.490 27.477USD -659 27.56 Profit of 2 on sale
2024-10-23SELL-2427.36027.490 27.477USD -659 27.56 Profit of 2 on sale
2024-10-22BUY13327.37027.695 27.662USD 3,679 27.75
2024-10-22BUY13327.37027.695 27.662USD 3,679 27.75
2024-10-21SELL-1,33027.75028.000 27.975USD -37,207 0.00 Loss of -37,207 on sale
2024-10-21SELL-1,33027.75028.000 27.975USD -37,207 0.00 Loss of -37,207 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of RPRX

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19877,43501,269,34869.1%
2025-09-18854,1562551,225,70969.7%
2025-09-17890,42801,130,88978.7%
2025-09-16849,69101,371,04262.0%
2025-09-151,310,0518751,800,47672.8%
2025-09-121,066,1208001,339,29279.6%
2025-09-111,220,1202831,532,65679.6%
2025-09-101,195,1197901,440,33383.0%
2025-09-091,259,8539241,521,80482.8%
2025-09-081,967,2801,0943,312,54759.4%
2025-09-052,792,92604,789,48758.3%
2025-09-04649,49701,396,64246.5%
2025-09-03741,51103,964,24418.7%
2025-09-021,164,4616211,836,12263.4%
2025-08-29568,8486441,099,44151.7%
2025-08-28343,4431,229665,67251.6%
2025-08-27718,529151,134,79763.3%
2025-08-26376,8063,158782,11648.2%
2025-08-25523,36001,666,11631.4%
2025-08-22416,9751,403983,55642.4%
2025-08-21515,9061789,60565.3%
2025-08-20668,9345571,359,61949.2%
2025-08-19282,3631,211801,13935.2%
2025-08-18470,777713735,14364.0%
2025-08-15370,8860849,95543.6%
2025-08-14437,27101,270,82534.4%
2025-08-13450,93002,187,21920.6%
2025-08-12378,7083211,366,73627.7%
2025-08-11566,6033221,321,77142.9%
2025-08-08732,3041,1411,058,55269.2%
2025-08-07637,7791411,478,11943.1%
2025-08-06968,026951,335,30672.5%
2025-08-05817,147971,153,95670.8%
2025-08-04562,562677830,96467.7%
2025-08-01356,771847641,24655.6%
2025-07-31550,713210657,91283.7%
2025-07-30529,655432816,35164.9%
2025-07-29600,85925752,37279.9%
2025-07-28682,7281,073824,97582.8%
2025-07-25351,99350514,20168.5%
2025-07-24396,41057557,22971.1%
2025-07-23289,2172,996787,22036.7%
2025-07-22460,4210666,17169.1%
2025-07-21489,8451,682693,05470.7%
2025-07-18355,3760587,43460.5%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy